Multidrug-resistant tuberculosis (MDR-TB) continues to threaten efforts to end the global TB epidemic. A new study in Sierra Leone led by LSTM has highlighted a high mortality rate amongst people with MDR-TB, with around 1 in 10 dying within 12 months after successfully completing treatment. (1/3)
